Comparison of leukemia-associated immunophenotype (LAIP)-based and different-from-normal (DfN)-based analysis of measurable residual disease (MRD) in patients with AML
Von Bonin M, Buecklein V, Krause S, Voelkl S, Rieger M, Berg T, Brendel C, Hoffmann J, Kramer M, Roehnert M, Oelschlaegel U, Subklewe M (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: KARGER
City/Town: BASEL
Pages Range: 87-88
Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT
Involved external institutions
Technische Universität Dresden
Germany (DE)
Deutsches Krebsforschungszentrum (DKFZ)
Germany (DE)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Universitätsklinikum Gießen und Marburg (UKGM)
Germany (DE)
Goethe-Universität Frankfurt am Main
Germany (DE)
Germany (DE)
Deutsches Krebsforschungszentrum (DKFZ)
Germany (DE)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Universitätsklinikum Gießen und Marburg (UKGM)
Germany (DE)
Goethe-Universität Frankfurt am Main
Germany (DE)
How to cite
APA:
Von Bonin, M., Buecklein, V., Krause, S., Voelkl, S., Rieger, M., Berg, T.,... Subklewe, M. (2019). Comparison of leukemia-associated immunophenotype (LAIP)-based and different-from-normal (DfN)-based analysis of measurable residual disease (MRD) in patients with AML. In ONCOLOGY RESEARCH AND TREATMENT (pp. 87-88). BASEL: KARGER.
MLA:
Von Bonin, M., et al. "Comparison of leukemia-associated immunophenotype (LAIP)-based and different-from-normal (DfN)-based analysis of measurable residual disease (MRD) in patients with AML." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2019. 87-88.
BibTeX: Download